tiprankstipranks
Extendicare (TSE:EXE)
TSX:EXE
Holding TSE:EXE?
Track your performance easily

Extendicare (EXE) Technical Analysis

176 Followers

Summary of all the Indicators

Overall Consensus
Buy
14Bullish
5Neutral
3Bearish
Technical Analysis Consensus
Neutral
3Bullish
5Neutral
2Bearish
Moving Average Consensus
Strong Buy
11Bullish
0Neutral
1Bearish
Extendicare’s (EXE) Moving Averages Convergence Divergence (MACD) indicator is 0.06, suggesting Extendicare is a Buy.
Extendicare’s (EXE) 20-Day exponential moving average is 10.25, while Extendicare’s (EXE) share price is C$10.31, making it a Buy.
Extendicare’s (EXE) 50-Day exponential moving average is 9.91, while Extendicare’s (EXE) share price is C$10.31, making it a Buy.

Extendicare (EXE) Pivot Points

Dec 22, 2024, 10:04 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
9.82
9.91
9.99
10.08
10.16
10.25
10.33
Fibonacci
9.91
9.97
10.02
10.08
10.14
10.19
10.25
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Extendicare (EXE) Moving Averages

Dec 22, 2024, 10:04 PM
Period
Simple
Exponential
MA5
10.14Buy
10.19Buy
MA10
10.28Buy
10.25Buy
MA20
10.42Sell
10.25Buy
MA50
9.84Buy
9.91Buy
MA100
9.25Buy
9.32Buy
MA200
8.22Buy
8.41Buy
Extendicare’s (EXE) 10-Day exponential moving average is 10.25, while Extendicare’s (EXE) share price is C$10.31, making it a Buy.
Extendicare’s (EXE) 100-Day exponential moving average is 9.32, while Extendicare’s (EXE) share price is C$10.31, making it a Buy.
Extendicare’s (EXE) stock price is C$10.31 and Extendicare’s (EXE) 50-day simple moving average is 9.84, creating a Buy signal.
Extendicare’s (EXE) stock price is C$10.31 and Extendicare’s (EXE) 100-day simple moving average is 9.25, creating a Buy signal.
Extendicare’s (EXE) stock price is C$10.31 and Extendicare’s (EXE) 200-day simple moving average is 8.22, creating a Buy signal.

Extendicare (EXE) Technical Indicators

Dec 22, 2024, 10:04 PM
Name
Value
Implied Action
RSI (14)
53.79
Neutral
STOCH (9,6)
20.28
Neutral
STOCHRSI (14)
15.46
Buy
MACD (12,26)
0.06
Buy
ADX (14)
31.51
Neutral
Williams %R
-63.74
Buy
CCI (14)
-68.53
Neutral
ATR (14)
0.24
-
Ultimate Oscillator
41.43
Neutral
ROC
-3.46
Sell
Extendicare’s (EXE) Relative Strength Index (RSI) is 53.79, creating a Neutral signal.
Extendicare’s (EXE) Trend Strength Indicator (ADX) is 31.51, creating a Neutral signal.
Extendicare’s (EXE) Commodity Channel Index (CCI) is -68.53, creating a Neutral signal.
Extendicare’s (EXE) Price Rate of Change (ROC) is -3.46, creating a Sell signal.

FAQ

Is EXE a Buy, Hold, or Sell?
Based on EXE’s technical indicators, EXE is a Buy.
    What is EXE’s RSI (14)?
    EXE’s RSI (14) is 53.79, which suggests EXE is a Neutral.
      What is EXE’s MACD?
      EXE’s MACD is 0.06, which suggests EXE is a Buy.
        What is EXE’s 5-day moving average?
        EXE’s 5-day moving average is 10.14, which suggests EXE is a Buy.
          What is EXE’s 20-day moving average?
          EXE 20-day moving average is 10.42, which suggests EXE is a Sell.
            What is EXE’s 50-day moving average?
            EXE’s 50-day moving average is 9.84, which suggests EXE is a Buy.
              What is EXE’s 200-day moving average?
              EXE’s 200-day moving average is 8.22, which suggests EXE is a Buy.
                What is EXE’s Williams % R (14)?
                EXE’s Williams % R (14) is -63.74, which suggests EXE is a Buy.
                  What is EXE’s CCI (14)?
                  EXE’s CCI (14) is -68.53, which suggests EXE is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis